PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS
Case Report: Hematopoietic stem cell transplantation (HSCT) is a treatment method that can provide cure for most hematological malignant diseases. In addition to hematological malignancy, HCT is also used as a treatment method in benign hematological diseases, solid tumors, and autoimmune diseases....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028943 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850253497328467968 |
|---|---|
| author | Muhammed Murati Yakup Ünsal Güler Delibalta Serdar Bedii Omay |
| author_facet | Muhammed Murati Yakup Ünsal Güler Delibalta Serdar Bedii Omay |
| author_sort | Muhammed Murati |
| collection | DOAJ |
| description | Case Report: Hematopoietic stem cell transplantation (HSCT) is a treatment method that can provide cure for most hematological malignant diseases. In addition to hematological malignancy, HCT is also used as a treatment method in benign hematological diseases, solid tumors, and autoimmune diseases. Autologous hematopoietic stem cell transplantation (AHCT) is the most common procedure performed in solid tumors. Transplantation is performed first as high-dose chemotherapy (HDC) and then as OHCT. In our transplant center between 2021 and 2023, were evaluated data of high-dose chemotherapy (HDC) and OHCT. Our first case is a 43-year-old female patient who received multiple treatments with the diagnosis of refractory primary peritoneal adenocarcinoma. Our second case is a 22-year-old male neuroblastoma patient who was first diagnosed with a retroperitoneal mass. Our third case is a 27-year-old male patient diagnosed with refractory Ewing Sarcoma. Our fourth patient is a 29-year-old male, who was diagnosed with refractory testicular cancer and to whom we performed a transplant. |
| format | Article |
| id | doaj-art-ae940b8d4c534836a0a485e88de173ee |
| institution | OA Journals |
| issn | 2531-1379 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj-art-ae940b8d4c534836a0a485e88de173ee2025-08-20T01:57:21ZengElsevierHematology, Transfusion and Cell Therapy2531-13792024-12-0146S6010.1016/j.htct.2024.11.051PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSISMuhammed Murati0Yakup Ünsal1Güler Delibalta2Serdar Bedii Omay3Emsey Hospital; Corresponding author.Emsey HospitalEmsey HospitalEmsey HospitalCase Report: Hematopoietic stem cell transplantation (HSCT) is a treatment method that can provide cure for most hematological malignant diseases. In addition to hematological malignancy, HCT is also used as a treatment method in benign hematological diseases, solid tumors, and autoimmune diseases. Autologous hematopoietic stem cell transplantation (AHCT) is the most common procedure performed in solid tumors. Transplantation is performed first as high-dose chemotherapy (HDC) and then as OHCT. In our transplant center between 2021 and 2023, were evaluated data of high-dose chemotherapy (HDC) and OHCT. Our first case is a 43-year-old female patient who received multiple treatments with the diagnosis of refractory primary peritoneal adenocarcinoma. Our second case is a 22-year-old male neuroblastoma patient who was first diagnosed with a retroperitoneal mass. Our third case is a 27-year-old male patient diagnosed with refractory Ewing Sarcoma. Our fourth patient is a 29-year-old male, who was diagnosed with refractory testicular cancer and to whom we performed a transplant.http://www.sciencedirect.com/science/article/pii/S2531137924028943 |
| spellingShingle | Muhammed Murati Yakup Ünsal Güler Delibalta Serdar Bedii Omay PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS Hematology, Transfusion and Cell Therapy |
| title | PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS |
| title_full | PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS |
| title_fullStr | PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS |
| title_full_unstemmed | PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS |
| title_short | PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS |
| title_sort | presentation of 4 cases of autologous hematopoietic stem cell transplantation after high dose chemotherapy with refractory solid tumor diagnosis |
| url | http://www.sciencedirect.com/science/article/pii/S2531137924028943 |
| work_keys_str_mv | AT muhammedmurati presentationof4casesofautologoushematopoieticstemcelltransplantationafterhighdosechemotherapywithrefractorysolidtumordiagnosis AT yakupunsal presentationof4casesofautologoushematopoieticstemcelltransplantationafterhighdosechemotherapywithrefractorysolidtumordiagnosis AT gulerdelibalta presentationof4casesofautologoushematopoieticstemcelltransplantationafterhighdosechemotherapywithrefractorysolidtumordiagnosis AT serdarbediiomay presentationof4casesofautologoushematopoieticstemcelltransplantationafterhighdosechemotherapywithrefractorysolidtumordiagnosis |